Increased inspiratory oxygen fractions (FIO2) using a conventional drug delivery nebuliser;Fracciones inspiratorias elevadas de O2 con el uso del dispositivo convencional de nebulización de fármacos

Archivos de Bronconeumologia

Volumn 46, Issue 5, 2010, Pages 230-237

  Gea, Joaquim ^a,b   Orozco Levi, Mauricio ^a,b   Gallart, Lluís ^c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Hypoventilation; Nebulisations; Oxygen therapy

Indexed keywords

OXYGEN; SODIUM CHLORIDE;

ARTICLE; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; GAS FLOW; HUMAN; HUMAN EXPERIMENT; MEDICAL NEBULIZER; MOUTH BREATHING; NEBULIZATION; NORMAL HUMAN; NOSE BREATHING; OXYGEN THERAPY; VOLUNTEER; DRUG DELIVERY SYSTEM; FEMALE; INHALATIONAL DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEBULIZER;

ADMINISTRATION, INHALATION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; OXYGEN; OXYGEN INHALATION THERAPY;

EID: 85047695982     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(10)70058-6     Document Type: Article

References (38)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. National Heart, Lung and Blood Institute. Update of the Management Sections. GOLD website (). http://www.goldcopd.com.
2. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Evidence-based guidelines for asthma management and prevention. GINA website (). http://www.ginasthma.com.
3. Friedman M. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease. Am J Med 1996, 100:30S-39S.
4. Tashkin D.P., Bleecker E., Braun S., Campbell S., DeGraff A.C., Hudgel D.W., et al. Results of a multicenter study of nebulized inhalant bronchodilator solutions. Am J Med 1996, 100:62S-69S.
5. Datta D., Vitale A., Lahiri B., Zu Wallack R. An ebaluation of nebulized levalbuterol in stable COPD. Chest 2003, 124:844-849.
6. Management of exacerbation of COPD. Thorax 2004, 59(Suppl 1):131-156. British Thoracic Society.
7. Barberá J.A., Peces-Barba G., Agustí A.G.N., Izquierdo J.L., Monsó E., Montemayor T., et al. Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37:297-316.
8. Celli B.R. Update on the management of COPD. Chest 2008, 133:1451-1462.
9. Jiménez-Murillo L., Montero F.J. Manejo urgente del paciente con EPOC descompensada. Medicina de Urgencias: Guía diagnóstica y protocolos de actuación 1999, Ed. Harcourt, Madrid, p. 241-245. 2a ed.
10. Robinson T.D., Freiberg D.B., Regnis J.A., Young I.H. The role of hypoventilation and ventilation-perfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2000, 161:1524-1529.
11. Núñez-Fernández M., Muñoz-Martínez M.J., Fernández-Villar A., Botana M.I., Botana M.I., Leiro V., et al. ¿Es segura la nebulización de broncodilatadores con alto flujo de oxígeno en pacientes hipercápnicos?. Pneuma 2006, 5:85-88.
12. O'Callaghan C., Barry P.W. The science of nebulised drug delivery. Thorax 1997, 52(Suppl 2):S31-S44.
13. Cameron P., Coleridge J., Epstein J., Teichtahl H. The safety of oxygen-driven nebulisers in patients with chronic hypoxaemia and hypercapnia. Emerg Med 1992, 4:159-162.
14. Lim T.K., Tan W.C. Acute carbon dioxide narcosis during inhalationals therapy with oxygen powered nebulisers in patients with cvhronci airflow limiotation. Ann Acad Med Singapore 1985, 14:439-441.
15. Charoenratanakul S., Borrirukwanit K., Lekuthai S., Satayawiwat W., Dejsomritrutai W. Is driving oxygen flow rate clinically important for nebulizer therapy in patients with COPD?. J Med Assoc Thai 1995, 78:670-676.
16. Giner J., Basualdo L.V., Casan P., Hernández C., Macián V., Martínez I., et al. Normativa sobre la utilización de fármacos inhalados. Normativas SEPAR. Arch Bronconeumol 2000, 36:34-43.
17. Higgins S. Oxygen versus medical air for nebulisers in patients with COPD. Evidence Centre Critical Appraisal. Series 2003: Therapy. Clayton (Australia): Monash University; p. 1-8.
18. Guyton A.C. Regulación de la Respiración. Tratado de Fisiología Médica 1996, 567-578. McGraw-Hill-Interamericana, Madrid. 9a ed. A.C. Guyton, J.E. Hall (Eds.).
19. Anthonisen N.R., Cherniack R.M. Ventilatory control in lung disease. Regulation of breathing. Part II. Chap 15 1981, 965-987. Marcel Dekker inc, New York. T.F. Hornbein (Ed.).
20. Berry R.B., Mahutte C.K., Kirsch J.L., Stansbury D.W., Light R.W. Does the hypoxic ventilatory response predict the oxygen-induced falls in ventilation in COPD?. Chest 1993, 103:820-824.
21. 2-induced change in ventilation and ventilatory drive in COPD. Am J Respir Crit Care Med 1997, 155:609-614.
22. Bradley C.A., Fleetham J.A., Anthionisen N.R. Ventilatory control in patients with hypoxemia due to obstructive lung disease. Am Rev Respir Dis 1979, 120:21-30.
23. Fleetham J.A., Bradley C.A., Kryger M.H., Anthionisen N.R. The effect of low flow oxygen therapy on the chemical control of ventilation in patients with hypoxemic COPD. Am Rev Respir Dis 1980, 122:833-840.
24. Dunn W.F., Nelson S.B., Hubmayr R.D. Oxygen-induced hypercarbia in obstructive pulmonary disease. Am Rev Respir Dis 1991, 144:526-530.
25. 2 in patients with chronic obstructive pulmonary disease in acute respiratory failure. Eur Respir J 1993, 6:619-624.
26. Sassoon C.S.H., Hassell K.T., Mahutte C.K. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. Am Rev Respir Dis 1987, 135:907-911.
27. 2 response and hypercapnia in severe chronic obstructive pulmonary disease. Eur Respir J 1998, 12:666-671.
28. Gundmunsson G., Gislason T.H., Lindberg E., Hallin R., Ulrik C.S., Brondum E., et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006, 7:109-116.
29. Denniston A.K., O'Brien C., Stableforth D. The use of oxygen in acute exacerbations of chronic obstructive pulmonary disease: a prospective audit of pre-hospital and hospital emergency management. Clin Med 2002, 2:449-451.
30. Plant P.K., Owen J.L., Elliott M.W. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000, 55:550-554.
31. 2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980, 122:747-754.
32. Muir J.F., Similowski T., Derenne J.P. Oxygen therapy during acute respiratory failure of chronic obstructive pulmonary disease. Acute Respiratory Failure in Chronic Obstructive Pulmonary Diseases 1996, 579-590. Marcel Dekker, New York. J.P. Derenne, W.A. Whitelaw, T. Similowski (Eds.).
33. Sandek K., Bratel T., Hellstrom G., Lagerstrand L. Ventilation-perfusion inequality and carbon dioxide sensitivity in hypoxaemic chronic obstructive pulmonary disease (COPD) and effects of 6 months of long-term oxygen treatment (LTOT). Clin Phsyiol 2001, 21:584-593.
34. Jubran A., Tobin M.J. Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator dependent patients. Chest 1990, 97:1420-1425.
35. Durrington H.J., Flubacher M., Ramsay C.F., Howard L.S.G.E., Harrison B.D.W. Initial oxygen management in patients with an acute exacerbation of chronic obstructive pulmonary disease. Q J Med 2005, 98:499-504.
36. Murphy R., Driscoll P., O'Driscoll R. Emergency oxygen therapy for COPD patients. Emerg Med 2001, 18:333-339.
37. Ballester E., Reyes A., Roca J., Guitart R., Wagner P.D., Rodriguez-Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989, 44:258-267.
38. Polverino E., Gómez F.P., Manrique H., Soler N., Roca J., Barberà J.A., et al. Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2007, 176:350-355.